Is there a generic version of Onglyza?

Onglyza (saxagliptin) is a brand name for the active ingredient saxagliptin. Onglyza is one of the newer medications developed to treat type 2 diabetes mellitus. The current patent for Onglyza will expire in February 2021. If no lawsuits or extensions are applied, it may be available in generic version soon after that date.